Compare ESPR & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESPR | BZH |
|---|---|---|
| Founded | 2008 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 660.1M | 717.3M |
| IPO Year | 2013 | 1994 |
| Metric | ESPR | BZH |
|---|---|---|
| Price | $3.70 | $22.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $6.86 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 7.0M | 477.9K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.52 |
| Revenue | $303,802,000.00 | ★ $2,371,555,000.00 |
| Revenue This Year | $25.45 | $7.40 |
| Revenue Next Year | N/A | $12.09 |
| P/E Ratio | ★ N/A | $14.80 |
| Revenue Growth | ★ 2.83 | 1.77 |
| 52 Week Low | $0.69 | $17.37 |
| 52 Week High | $4.03 | $34.39 |
| Indicator | ESPR | BZH |
|---|---|---|
| Relative Strength Index (RSI) | 63.61 | 50.83 |
| Support Level | $3.59 | $22.43 |
| Resistance Level | $3.91 | $23.85 |
| Average True Range (ATR) | 0.24 | 0.90 |
| MACD | 0.05 | 0.25 |
| Stochastic Oscillator | 77.74 | 69.00 |
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.